PERCEVAL SUTURELESS HEART VALVE
Corcym S.r.l. · Decision date Oct 28, 2025
What did the FDA decide?
FDA records P150011/S033 as a supplement to PMA P150011, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 28, 2025.
FDA approval order statement
implementing an alternative vaporized hydrogen peroxide generator
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 28, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P150011/S033
- Regulatory pathway
- PMA supplement
- Applicant
- Corcym S.r.l.
- Product code
- LWR
- Decision code
- OK30
- Decision date
- Oct 28, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: heart-valve, non-allograft tissue.
- Applicant
- Corcym S.r.l.
- Product code
- LWR
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P150011/S033 received
Application receipt date recorded by FDA.
P150011/S034 · Related supplement
Perceval Sutureless Heart Valve
P150011/S033 · FDA decision
30-Day Notice
P150011/S035 · Related supplement
Perceval Sutureless Heart Valve
Timeline entries are records held by MedtechLedger for P150011. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150011
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Perceval Sutureless Heart ValveP150011/S034 | Corcym S.r.l. | PMA supplement | Oct 28, 2025 | FDA |
Perceval Sutureless Heart ValveP150011/S035 | Corcym S.r.l. | PMA supplement | Dec 22, 2025 | FDA |
Explore the linked device profile
Other records with product code LWR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EDWARDS INTUITY Elite Valve System (8300AB)P150036/S081 | Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 18, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Aug 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Corcym S.r.l.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Via Crescentino Sn, Saluggia, 13040
Sources and methodology
- Original FDA record: P150011/S033
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records